Inventor
Kyle D. Monroe
Inventor
Pittsford, NY, US
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07DHeterocyclic compounds19%
C07KPeptides14%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium10%
C07BGeneral methods of organic chemistry7%
C07CAcyclic or carbocyclic compounds7%
PatentTitleYear
11,124,567Anti-TREM2 antibodies and methods of use thereof202111,026,957Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands202110,980,801Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use202110,865,185Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activity202010,821,106Composition and methods of use of novel phenylalanine small organic compounds to directly modulate PCSK9 protein activity202010,688,114Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity202010,568,882Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use202010,307,433Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity201910,287,317Proprotein convertase subtilisin kexin type 9 (PCSK9) allosteric binding ligands to modulate serum low density lipoprotein (LDL) levels201910,034,892Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity2018Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2018–2021Patents assigned to SRX CARDIO LLC (9)· patent assignee history
2018–2021Based in Pittsford, NY, US· patent location history
2020Patents assigned to SXR CARDIO LLC (1)· patent assignee history
2021Patents assigned to DENALI THERAPEUTICS INC (1)· patent assignee history
2021Based in South San Francisco, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SRX CARDIO LLC | 9 | 2018–2021 |
| DENALI THERAPEUTICS INC | 1 | 2021 |
| SXR CARDIO LLC | 1 | 2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Pittsford, New York, US | 9 | 2018–2021 |
| South San Francisco, California, US | 1 | 2021 |